Table 1.
# | Age | Sex | BMI (kg/m2)a | Comorbidity | ESBL-Producer | ESBL-neg.b after 1st FMTc | ESBL-neg. after 2nd FMT | Donor FMT 1 | Donor FMT 2 |
---|---|---|---|---|---|---|---|---|---|
1 | 58 | M | 19 | ESRDd, PDe, CVDf | E. coli g | Y | – | 1 | – |
2 | 47 | M | 27 | Tetraplegia, rUTIh | E. coli | N | – | 1 | – |
3 | 65 | M | 25 | Renal Txj, rUTI | E. coli | N | N | 1 | 1 |
4 | 61 | M | 24 | rUTI | K. p j | N | – | 1 | – |
5 | 29 | F | 35 | rUTI | E. coli | N | Y | 1 | 2 |
6 | 56 | F | 28 | RUTI | E. coli | N | N | 1 | 2 |
7 | 70 | F | 28 | Renal Tx, rUTI | K. p, E. coli | N | N | 1 | 2 |
8 | 59 | F | 20 | Renal Tx, rUTI, HBVk | E. coli | Y | – | 1 | – |
9 | 61 | F | 28 | rUTI | E. coli | N | Y | 1 | 1 |
10 | 57 | F | 26 | ESRD, rUTI | E. coli | N | – | 2 | – |
11 | 76 | F | 23 | rUTI | E. coli | Y | – | 2 | – |
12 | 70 | M | 24 | Renal Tx, rUTI, T2Dl | E. coli | N | – | 1 | – |
13 | 59 | F | 29 | Renal Tx | K. p | N | N | 1 | 1 |
14 | 58 | F | 36 | rUTI | E. coli | N | Y | 1 | 2 |
15 | 21 | F | 24 | rUTI | E. coli | N | – | 1 | – |
aBody mass index, b extended-spectrum beta lactamase producer-negative, c fecal microbiota transplantation, d end-stage renal disease, e peritoneal dialysis, f cardiovascular disease, g Escherichia coli, h recurring urinary tract infections, i transplant, j Klebsiella pneumoniae, k Hepatitis B virus, l type 2 diabetes. Patient 7 had (only) K. pneumoniae before the 1st FMT and (only) E. coli before the second FMT